Stakeholder Opinions: Skin and Soft Tissue Infections
- Published: July 2009
Hospital Insight Series: MRSA Infections (Europe)
Hospital Insight Series: MRSA Infections (Europe)
- Published: December 2011
- Region: World
- 227 Pages
- Decision Resources, Inc
Methicillin-resistant Staphylococcus aureus (MRSA) is a clinically important pathogen that causes serious infections, including skin and skin structure infections, bloodstream infections, lower respiratory tract infections, and bone and joint infections. Drug resistance in MRSA and MRSA’s decreased susceptibility to IV vancomycin, the mainstay drug for the treatment of MRSA, poses significant challenges in the treatment of MRSA infections, yet provides opportunities for the uptake of other and emerging MRSA therapies in the European MRSA market.
Hospital Insight Series is a syndicated report series that analyzes the hospital antibiotic prescribing patterns for the treatment of key infections and infections caused by emerging and clinically-important pathogens, such as methicillin-resistant Staphylococcus aureus (MRSA). This report provides insight and analysis of the MRSA infection market in Europe, focusing on the key therapies for the management of MRSA infections in the hospital.
Through audit data from AMR’s Hospital Antibiotic Market Guide and primary research with infectious diseases specialists, we are able to understand dynamics of product usage, physicians’ treatment patterns, factors that influence prescribing patterns, and reactions to and perceptions of emerging and novel therapies.
Executive Summary and Key Findings
Introduction
Methodology
MRSA Patient Population Analysis
Indication Analysis
Prescriber Analysis
Physician Insight and Treatment Analysis
Product Analysis
Novel and Emerging Therapies
| Format | Properties | |
|---|---|---|
| Electronic (PDF) | The report will be emailed to you. The report is sent in PDF format. | This is a single user license, allowing one specific user access to the product. |
Note: Product cover images may vary from those shown
RELATED PRODUCTS
-
FROM
-
Pipeline Insight: Antibacterials
- Published: February 2011
FROM -
MRSA Drug Futures
- Language: English
- 108 Pages
- Published: September 2010
- Region: World
FROM -
Hospital-Acquired Infection Incidence - Trends in Australia
- Language: English
- 93 Pages
- Published: May 2011
- Region: Australia
FROM -
Hospital Insight Series: Complicated Skin and Skin Structure Infections (Europe)
- Language: English
- 239 Pages
- Published: December 2011
- Region: World
-
Methicillin-Resistant Staphylococcus Aureus (Event Driven)
- Language: English
- 189 Pages
- Published: December 2011
- Region: World
-
Hospital-Treated Infections (Event Driven)
- Language: English
- 259 Pages
- Published: November 2012
- Region: World
-
Hospital Insight Series: Diabetic Foot Infections, United States, 2011
- Language: English
- 226 Pages
- Published: November 2011
- Region: World
-
MRSA. Edition No. 2
- Language: English
- 296 Pages
- Published: May 2010
- Region: World
-
MRSA. Edition No. 2
- Language: English
- 296 Pages
- Published: May 2010
- Region: World
